187 related articles for article (PubMed ID: 35528466)
1. Embryologic and hormonal contributors to prostate cancer in transgender women.
Gaglani S; Purohit RS; Tewari AK; Kyprianou N; Lundon DJ
Am J Clin Exp Urol; 2022; 10(2):63-72. PubMed ID: 35528466
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer in transgender women: what does a urologist need to know?
Bertoncelli Tanaka M; Sahota K; Burn J; Falconer A; Winkler M; Ahmed HU; Rashid TG;
BJU Int; 2022 Jan; 129(1):113-122. PubMed ID: 34157213
[TBL] [Abstract][Full Text] [Related]
4. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
[TBL] [Abstract][Full Text] [Related]
5. Incidence of prostate cancer in transgender women in the US: a large database analysis.
Loria M; Gilbert D; Tabernacki T; Maravillas MA; McNamara M; Gupta S; Mishra K
Prostate Cancer Prostatic Dis; 2024 Feb; ():. PubMed ID: 38326392
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
[TBL] [Abstract][Full Text] [Related]
7. [Hormone treatment of transgender people: Long-term health effects and safety].
de Blok CJM; Wiepjes CM; Nota NM; den Heijer M
Ned Tijdschr Geneeskd; 2020 Jul; 164():. PubMed ID: 32757514
[TBL] [Abstract][Full Text] [Related]
8. Gender-Affirming Hormone Therapy Modifies the CpG Methylation Pattern of the ESR1 Gene Promoter After Six Months of Treatment in Transmen.
Fernández R; Ramírez K; Gómez-Gil E; Cortés-Cortés J; Mora M; Aranda G; Zayas ED; Esteva I; Almaraz MC; Guillamon A; Pásaro E
J Sex Med; 2020 Sep; 17(9):1795-1806. PubMed ID: 32636163
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Factors Associated With Gender-Affirming Surgery Among Transgender Women & Transgender Men in a Community-Based Clinic in Metro Manila, Philippines: A Retrospective Study.
Eustaquio PC; Castelo AV; Araña YS; Corciega JOL; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
Sex Med; 2022 Apr; 10(2):100497. PubMed ID: 35247792
[TBL] [Abstract][Full Text] [Related]
10. Transgender individuals' cancer survivorship: Results of a cross-sectional study.
Boehmer U; Gereige J; Winter M; Ozonoff A; Scout N
Cancer; 2020 Jun; 126(12):2829-2836. PubMed ID: 32134515
[TBL] [Abstract][Full Text] [Related]
11. Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy.
Silva ED; Fighera TM; Allgayer RM; Lobato MIR; Spritzer PM
Front Psychiatry; 2021; 12():621075. PubMed ID: 34381383
[No Abstract] [Full Text] [Related]
12. Prostate cancer in transgender women.
Ingham MD; Lee RJ; MacDermed D; Olumi AF
Urol Oncol; 2018 Dec; 36(12):518-525. PubMed ID: 30322726
[TBL] [Abstract][Full Text] [Related]
13. Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons.
Defreyne J; Van de Bruaene LDL; Rietzschel E; Van Schuylenbergh J; T'Sjoen GGR
Clin Chem; 2019 Jan; 65(1):119-134. PubMed ID: 30602477
[TBL] [Abstract][Full Text] [Related]
14. Gender-affirming hormone treatment causes changes in gender phenotype in a 12-lead electrocardiogram.
Saito N; Nagahara D; Ichihara K; Masumori N; Miura T; Takahashi S
Heart Rhythm; 2021 Jul; 18(7):1203-1209. PubMed ID: 33706005
[TBL] [Abstract][Full Text] [Related]
15. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
Glintborg D; T'Sjoen G; Ravn P; Andersen MS
Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
[TBL] [Abstract][Full Text] [Related]
16. Neural and Hormonal Correlates of Sexual Arousal in Transgender Persons.
Mueller SC; Wierckx K; T'Sjoen G
J Sex Med; 2020 Dec; 17(12):2495-2507. PubMed ID: 33223427
[TBL] [Abstract][Full Text] [Related]
17. Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women.
de Nie I; Mulder CL; Meißner A; Schut Y; Holleman EM; van der Sluis WB; Hannema SE; den Heijer M; Huirne J; van Pelt AMM; van Mello NM
Hum Reprod; 2022 Jan; 37(2):297-308. PubMed ID: 34791270
[TBL] [Abstract][Full Text] [Related]
18. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
Defreyne J; T'Sjoen G; Bouman WP; Brewin N; Arcelus J
J Sex Med; 2018 May; 15(5):768-776. PubMed ID: 29699761
[TBL] [Abstract][Full Text] [Related]
19. The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand.
Ittiphisit S; Amponnavarat S; Manaboriboon N; Korpaisarn S
Sex Med; 2022 Jun; 10(3):100513. PubMed ID: 35428019
[TBL] [Abstract][Full Text] [Related]
20. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
